Literature DB >> 18472177

Molecular evolution of the RNA polymerase II CTD.

Rob D Chapman1, Martin Heidemann, Corinna Hintermair, Dirk Eick.   

Abstract

In higher eukaryotes, an unusual C-terminal domain (CTD) is crucial to the function of RNA polymerase II in transcription. The CTD consists of multiple heptapeptide repeats; differences in the number of repeats between organisms and their degree of conservation have intrigued researchers for two decades. Here, we review the evolution of the CTD at the molecular level. Several primitive motifs have been integrated into compound heptads that can be readily amplified. The selection of phosphorylatable residues in the heptad repeat provided the opportunity for advanced gene regulation in eukaryotes. Current findings suggest that the CTD should be considered as a collection of continuous overlapping motifs as opposed to a specific functional unit defined by a heptad.

Mesh:

Substances:

Year:  2008        PMID: 18472177     DOI: 10.1016/j.tig.2008.03.010

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  85 in total

1.  Noncanonical tandem SH2 enables interaction of elongation factor Spt6 with RNA polymerase II.

Authors:  Marie-Laure Diebold; Erin Loeliger; Michael Koch; Fred Winston; Jean Cavarelli; Christophe Romier
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Genetic organization, length conservation, and evolution of RNA polymerase II carboxyl-terminal domain.

Authors:  Pengda Liu; John M Kenney; John W Stiller; Arno L Greenleaf
Journal:  Mol Biol Evol       Date:  2010-06-17       Impact factor: 16.240

3.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

4.  The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase.

Authors:  Barbara J Natalizio; Nicole D Robson-Dixon; Mariano A Garcia-Blanco
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

Review 5.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

6.  Serine phosphorylation and proline isomerization in RNAP II CTD control recruitment of Nrd1.

Authors:  Karel Kubicek; Hana Cerna; Peter Holub; Josef Pasulka; Dominika Hrossova; Frank Loehr; Ctirad Hofr; Stepanka Vanacova; Richard Stefl
Journal:  Genes Dev       Date:  2012-08-14       Impact factor: 11.361

7.  Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins.

Authors:  Ibraheem Ali; Diego Garrido Ruiz; Zuyao Ni; Jeffrey R Johnson; Heng Zhang; Pao-Chen Li; Mir M Khalid; Ryan J Conrad; Xinghua Guo; Jinrong Min; Jack Greenblatt; Matthew Jacobson; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2019-05-01       Impact factor: 17.970

8.  The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation.

Authors:  Sunnie M Yoh; Joseph S Lucas; Katherine A Jones
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

9.  RNA polymerase II C-terminal heptarepeat domain Ser-7 phosphorylation is established in a mediator-dependent fashion.

Authors:  Stefan Boeing; Caroline Rigault; Martin Heidemann; Dirk Eick; Michael Meisterernst
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

10.  An unusual recent expansion of the C-terminal domain of RNA polymerase II in primate malaria parasites features a motif otherwise found only in mammalian polymerases.

Authors:  Sandeep P Kishore; Susan L Perkins; Thomas J Templeton; Kirk W Deitsch
Journal:  J Mol Evol       Date:  2009-05-16       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.